Related Experiment Video
Updated: Mar 23, 2026

Murine Appendectomy Model of Chronic Colitis Associated Colorectal Cancer by Precise Localization of Caecal Patch
Published on: August 24, 2019
Amyloid Goiter Secondary to Ulcerative Colitis
Bunyamin Aydin1, Yavuz Savas Koca2, Tugba Koca3
1Division of Endocrinology and Metabolism, Department of Internal Medicine, Suleyman Demirel University, School of Medicine, 32200 Isparta, Turkey.
This study details a rare case of diffuse amyloid goiter (AG) caused by secondary amyloidosis linked to ulcerative colitis. Diagnosis relies on histopathology, not imaging, highlighting a rare association between IBD and thyroid amyloidosis.
Area of Science:
- Endocrinology
- Gastroenterology
- Pathology
Background:
- Diffuse amyloid goiter (AG) involves amyloid deposition in the thyroid.
- AG can stem from primary or secondary amyloidosis.
- Secondary amyloidosis is rarely linked to inflammatory bowel diseases (IBD), particularly ulcerative colitis (UC).
Purpose of the Study:
- To report a rare case of diffuse amyloid goiter (AG) secondary to ulcerative colitis (UC).
- To emphasize the diagnostic challenges and methods for secondary amyloid goiter.
Main Methods:
- Case presentation of a 35-year-old male patient.
- Review of diagnostic approaches for secondary amyloid goiter.
- Histopathologic analysis and histochemical staining for definitive diagnosis.
Main Results:
- The patient presented with diffuse amyloid goiter (AG).
- The condition was attributed to secondary amyloidosis associated with ulcerative colitis (UC).
- Medullary thyroid cancer was considered in the differential diagnosis.
Conclusions:
- Diffuse amyloid goiter caused by UC-associated secondary amyloidosis is exceptionally rare.
- Histopathology is crucial for diagnosing secondary amyloid goiter, as imaging and biochemical tests are insufficient.
- This case underscores the importance of considering rare systemic associations in IBD patients.
Related Concept Videos
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Drugs for Treatment of Ulcerative Colitis in IBD

